ATE224896T1 - Verfahren zur herstellung von enantiomerisch reinen imidazol-verbindungen - Google Patents

Verfahren zur herstellung von enantiomerisch reinen imidazol-verbindungen

Info

Publication number
ATE224896T1
ATE224896T1 AT96202829T AT96202829T ATE224896T1 AT E224896 T1 ATE224896 T1 AT E224896T1 AT 96202829 T AT96202829 T AT 96202829T AT 96202829 T AT96202829 T AT 96202829T AT E224896 T1 ATE224896 T1 AT E224896T1
Authority
AT
Austria
Prior art keywords
addition salt
acid
mixture
enantiomer
compound
Prior art date
Application number
AT96202829T
Other languages
English (en)
Inventor
Der Meij Paulus Franciscus Van
Jan-Maarten Verbeek
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Application granted granted Critical
Publication of ATE224896T1 publication Critical patent/ATE224896T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT96202829T 1995-10-13 1996-10-10 Verfahren zur herstellung von enantiomerisch reinen imidazol-verbindungen ATE224896T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95202765 1995-10-13

Publications (1)

Publication Number Publication Date
ATE224896T1 true ATE224896T1 (de) 2002-10-15

Family

ID=8220714

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96202829T ATE224896T1 (de) 1995-10-13 1996-10-10 Verfahren zur herstellung von enantiomerisch reinen imidazol-verbindungen

Country Status (23)

Country Link
US (1) US5663343A (de)
EP (1) EP0768309B1 (de)
JP (2) JP4590038B2 (de)
KR (1) KR100459745B1 (de)
CN (1) CN1060774C (de)
AT (1) ATE224896T1 (de)
AU (1) AU702594B2 (de)
CA (1) CA2187484C (de)
CZ (1) CZ288042B6 (de)
DE (1) DE69623900T2 (de)
DK (1) DK0768309T3 (de)
DZ (1) DZ2104A1 (de)
ES (1) ES2183908T3 (de)
HU (1) HU226620B1 (de)
IL (1) IL119400A (de)
NO (1) NO307257B1 (de)
NZ (1) NZ299562A (de)
PT (1) PT768309E (de)
RU (1) RU2162085C2 (de)
SK (1) SK283471B6 (de)
TW (1) TW513423B (de)
UA (1) UA48947C2 (de)
ZA (1) ZA968525B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19813661A1 (de) * 1997-08-01 1999-02-04 Solvay Pharm Gmbh Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron
US6372919B1 (en) * 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
RU2213562C2 (ru) * 2001-03-14 2003-10-10 Научно-исследовательский институт фармакологии РАМН Лекарственная композиция
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US7015333B2 (en) * 2002-11-18 2006-03-21 Solvay Pharmaceuticals B.V. Process for preparation of imidazolyl compounds
EP1424337A1 (de) * 2002-11-26 2004-06-02 Solvay Pharmaceuticals GmbH 4-Hydroxyderivate von 5,6,9,10-Tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-on
JP2006516976A (ja) * 2003-01-13 2006-07-13 ダイノゲン ファーマシューティカルズ,インコーポレイテッド 機能性腸障害を処置する方法
JP2006516977A (ja) * 2003-01-13 2006-07-13 ダイノゲン ファーマシューティカルズ,インコーポレイテッド 悪心、嘔吐、レッチング、またはそれらの任意の組み合わせの治療方法
EP1539181B1 (de) * 2003-04-04 2007-06-27 Dynogen Pharmaceuticals Inc. Methode zur behandlung von erkrankungen der unteren harnwege
US20090018351A1 (en) * 2003-11-12 2009-01-15 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20080045725A1 (en) 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
JP5156222B2 (ja) * 2006-11-28 2013-03-06 エムキュア ファーマシューティカルズ リミテッド 制吐作用化合物の新たな製造方法
GB0910373D0 (en) * 2009-06-16 2009-07-29 Filtrona Int Ltd Tabacco smoke filter
US9806720B1 (en) * 2016-10-07 2017-10-31 Analog Devices Global Compound semiconductor based inverter
CN112424149B (zh) 2018-05-18 2023-06-23 库拉肿瘤学公司 替吡法尼的合成

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7413843A (nl) * 1974-10-23 1976-04-27 Stamicarbon Optische scheiding van fenylglycine-amide.
US4463176A (en) * 1982-09-13 1984-07-31 Mead Johnson & Company Process for resolution of optical isomers
US4849527A (en) * 1982-09-13 1989-07-18 Bristol-Myers Company Process for resolution of optical isomers
SE460359B (sv) * 1984-01-25 1989-10-02 Glaxo Group Ltd 3-imidazolylmetyltetrahydrokarbazoloner, foerfarande foer framstaellning av dessa och en farmaceutisk komposition
DE3885357T2 (de) * 1987-06-29 1994-03-24 Duphar Int Res Anellierte Indolderivate.
GB8812636D0 (en) * 1988-05-27 1988-06-29 Glaxo Group Ltd Chemical compounds
US5049563A (en) * 1988-07-07 1991-09-17 Duphar International Research B.V. Annelated indoleketones with an imidazolylalkyl substituent
DE4238553A1 (de) * 1992-11-14 1994-05-19 Kali Chemie Pharma Gmbh Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel
RU2041876C1 (ru) * 1993-12-29 1995-08-20 Научно-производственный центр "Фармзащита" Способ получения 1,2,3,9- тетрагидро-9-метил-3- [(2-метил-1н- имидазол-1-ил) метил]-4н- карбазол-4-она или его солей, или их гидратов, и промежуточные продукты для их синтеза

Also Published As

Publication number Publication date
SK283471B6 (sk) 2003-08-05
HK1000446A1 (en) 2003-01-10
HUP9602778A2 (en) 1997-05-28
CN1160053A (zh) 1997-09-24
JP2010159292A (ja) 2010-07-22
NO964282L (no) 1997-04-14
IL119400A0 (en) 1997-01-10
US5663343A (en) 1997-09-02
IL119400A (en) 2000-02-29
DK0768309T3 (da) 2002-12-09
SK128796A3 (en) 1997-05-07
NZ299562A (en) 1997-09-22
JPH09183779A (ja) 1997-07-15
CZ288042B6 (cs) 2001-04-11
ZA968525B (en) 1997-05-20
CA2187484A1 (en) 1997-04-14
UA48947C2 (uk) 2002-09-16
HU226620B1 (en) 2009-04-28
EP0768309A1 (de) 1997-04-16
NO307257B1 (no) 2000-03-06
AU702594B2 (en) 1999-02-25
EP0768309B1 (de) 2002-09-25
PT768309E (pt) 2003-02-28
HUP9602778A3 (en) 1997-08-28
DE69623900T2 (de) 2003-07-31
DE69623900D1 (de) 2002-10-31
HU9602778D0 (en) 1996-11-28
RU2162085C2 (ru) 2001-01-20
DZ2104A1 (fr) 2002-07-22
KR970021080A (ko) 1997-05-28
TW513423B (en) 2002-12-11
CN1060774C (zh) 2001-01-17
CZ294796A3 (en) 1997-05-14
CA2187484C (en) 2006-09-05
AU6585696A (en) 1997-04-17
KR100459745B1 (ko) 2005-01-26
ES2183908T3 (es) 2003-04-01
NO964282D0 (no) 1996-10-09
JP4590038B2 (ja) 2010-12-01

Similar Documents

Publication Publication Date Title
ATE224896T1 (de) Verfahren zur herstellung von enantiomerisch reinen imidazol-verbindungen
US5281722A (en) Preparation and use of salts of the pure enantiomers of alpha-lipoic acid
FI110776B (fi) Menetelmä substituoitujen fenyylipropionihappojen oleellisesti puhtaiden enantiomeerien valmistamiseksi
RU96120366A (ru) Способ получения энантиомерно чистых соединений имидазолила, энантиомерно чистая кислая аддитивная соль имидазолила и в-пироглутаминовой кислоты
FI117438B (fi) Menetelmä optisesti rikastetun bupivakaiinin valmistamiseksi
JP4015696B2 (ja) レボブピバカインと同類のピペリジンカルボキサニリド麻酔剤の製造に用いるラセミ化法
RU94046047A (ru) Производные аминоуксусной кислоты в виде рацемата или d- и l-энантиомеров и их фармацевтически приемлемые соли, способ получения d- и l-энантиомеров производных аминоуксусной кислоты или их фармацевтически приемлемых солей и промежуточные d- и l-энантиомеры аминоуксусной кислоты в виде цинхонидиновой соли
EP0220435B1 (de) Verfahren zur Herstellung optisch aktiver Halbester
ATE118476T1 (de) Verfahren zur herstellung von l-carnitin aus d,l- carnitinnitrilsalzen.
SK140898A3 (en) Improved process for the production of enantiomerically-pure azetidine-2-carboxylic acid
EP0970049B1 (de) Verfahren zur herstellung von enantiomerisch angereicherten n-acylazetidin-2-carbonsäuren
KR940002220A (ko) 광학활성 메티오닌아미드를 제조하는 방법
PL343556A1 (en) Method for producing enantiomer-free n-methyl-n- [(1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide
JPS6323824A (ja) 酸性α−水素を有するアミンの光学分割およびラセミ化方法
JPH10506384A (ja) 二環式ラクタム鏡像体の分離法
Schjelderup et al. The absolute configuration of oxyphencyclimine, a parasympatholytic drug. Syntheses of both enantiomers
US4584313A (en) (Substituted-phenyl)-5-oxo-2-pyrrolidinepropanoic acids and esters thereof, and use for reversing electroconvulsive shock-induced amnesia
HU205594B (en) Process for producing optical isomeres of cyclopropane-carboxylic acids5
ATE212615T1 (de) Verfahren zur herstellung von (1s,2r)-1-amino-2- indanol-(r,r)-tartrate methanol solvat
DK0556909T3 (da) Fremgangsmåde til fremstilling af (R) - og (S) - 1,2-isopropylildenglycol
WO1990002118A1 (en) Derivatives and precursors of captopril and its analogues
RU96118236A (ru) 8-галоген-6-гидроксиоктановые кислоты, их эфиры, соли, способы их получения и применение
WO1990002732A1 (en) Methods for preparing captopril and its analogues
ATE198189T1 (de) Synthese von optisch aktivem aminoindanol

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner